Medistep Healthcare IPO Listing: Stock Lists at 23% Premium on NSE SME

Medistep Healthcare IPO Listing: From a Strong Debut to Lower Circuit Close – A Deep Dive into the ₹43 Share’s Market Entry

Medistep Healthcare, a promising player in India’s healthcare and hygiene sector, made a notable entry on the NSE SME platform today.

The company’s Initial Public Offering (IPO), valued at ₹16.10 crore, captured significant investor interest when it opened for subscription from August 8 to August 12, 2025.

The IPO saw an extraordinary subscription rate of over 382 times overall, highlighting robust market enthusiasm for the company’s business prospects.

The IPO Listing Day: Early Gains Followed by Market Correction

Medistep Healthcare’s shares were priced at ₹43 each in the IPO, drawing attention for their attractive valuation given the company’s rapid growth trajectory and product portfolio.

On the first day of trading, the stock opened at ₹53 on the NSE SME platform, translating to a handsome listing gain of approximately 23.26% for IPO investors.

This early surge reflected strong demand and optimism among investors eager to participate in the company’s public market journey.

However, the initial euphoria was tempered later in the trading session as the stock price corrected downward, hitting the lower circuit limit of ₹50.35. The shares closed at this price, still representing a respectable gain of 17.09% from the IPO price.

The movement to the lower circuit suggests some short-term profit booking or volatility common with SME listings, where liquidity can be limited and price swings more pronounced.

Despite this correction, the overall positive listing performance is a promising sign for the company’s future as a publicly traded firm.

Investor Interest: A Testament to Medistep Healthcare’s Potential

The IPO’s remarkable subscription levels speak volumes about investor confidence. The offering was oversubscribed more than 382 times, with retail investors showing extraordinary interest by subscribing 461 times their quota.

This overwhelming demand underscores the growing appetite for quality healthcare and hygiene-related companies in India’s capital markets.

The IPO issued 37.44 lakh new equity shares, each with a face value of ₹10, raising a total of ₹16.10 crore. The high subscription ratio indicates that investors see significant growth potential in Medistep Healthcare’s business model and product portfolio.

Such intense interest can also be attributed to the company’s diversified product range, which taps into multiple growing market segments including sanitary pads, nutraceuticals, energy powders, intimate care, and surgical products—categories with increasing demand driven by rising health awareness and changing consumer lifestyles in India.

Utilization of IPO Proceeds: Fueling Expansion and Operational Efficiency

A critical aspect for investors assessing any IPO is how the company plans to deploy the capital raised. Medistep Healthcare has laid out a clear roadmap for using the ₹16.10 crore proceeds:

• Investment in Plant and Machinery: ₹51 lakh will be allocated to purchase new machinery, aimed at expanding manufacturing capacity and improving production efficiency. This step is vital to support the company’s growth plans and meet the rising demand for its products.
• Working Capital Requirements: The largest portion, ₹12.34 crore, is earmarked for working capital. This allocation will ensure smoother operational flow, enabling the company to maintain sufficient inventory levels, manage receivables, and handle day-to-day expenses effectively.
• General Corporate Purposes: The remainder of the funds will be used for general corporate purposes, providing financial flexibility to support strategic initiatives such as marketing, product development, and potential business collaborations.

By prioritizing capacity expansion and operational efficiency, Medistep Healthcare aims to strengthen its competitive positioning and accelerate growth.

Company Overview: A Young but Fast-Growing Enterprise in Healthcare and Hygiene

Established only recently in June 2023, Medistep Healthcare has quickly built a diversified product portfolio catering to essential healthcare needs.

The company manufactures a variety of products including sanitary pads, energy powders, nutraceuticals, intimate care and hygiene products, as well as surgical goods.

This broad range allows the company to tap into several fast-growing segments of the healthcare market:

• Sanitary Pads: With increasing awareness about feminine hygiene and a push towards affordable, quality products, this segment is witnessing robust demand across urban and rural India.
• Nutraceuticals and Energy Powders: Health supplements and energy-boosting powders have become staples among health-conscious consumers, further fueled by lifestyle changes and pandemic-driven health awareness.
• Intimate and Surgical Products: Growing medical infrastructure and hygiene consciousness continue to drive demand for surgical and intimate care items.

Financial Performance: Strong Growth with Improving Profitability

Despite being a relatively new company, Medistep Healthcare has exhibited impressive financial growth since inception.

The company’s net profit grew from ₹92 lakh in FY 2023 to ₹3.33 crore in FY 2024, further increasing to ₹4.14 crore in FY 2025.

This strong upward trend in profitability is a positive indicator of the company’s operational efficiency and market acceptance.

Total income also demonstrated a healthy compound annual growth rate (CAGR) of over 33% during this period, reaching ₹49.66 crore in FY 2025. Such rapid revenue growth combined with improving margins positions Medistep Healthcare as a rising player in its industry.

On the debt front, the company maintained a conservative profile, with debt levels rising modestly from ₹53 lakh in FY 2023 to ₹64 lakh in FY 2025.

This manageable debt load alongside strong earnings growth suggests financial prudence, enabling the company to pursue growth without undue financial risk.

Market Outlook and Investment Considerations

Medistep Healthcare’s entry into the public market comes at a time when consumer health and hygiene sectors are expanding rapidly, driven by increasing awareness, higher disposable incomes, and evolving consumer preferences.

The company’s diversified product base and strategic use of IPO funds to boost capacity and working capital give it a solid foundation to capitalize on these trends.

That said, as with many SME stocks, investors should be mindful of potential volatility in the short term, as seen in the initial trading day’s price swings.

Liquidity in SME exchanges can be lower compared to larger exchanges, which may lead to sharper price movements.

Long-term investors will likely focus on how well the company executes its growth plans, scales operations, manages competition, and sustains profitability.

The initial market response combined with the company’s solid fundamentals provides a cautiously optimistic outlook.

Final Thoughts: Medistep Healthcare’s Promising Journey as a Listed Entity

Medistep Healthcare’s IPO and subsequent listing reflect strong market interest in healthcare manufacturing companies addressing fundamental consumer needs.

The initial listing gain rewarded early investors, even though the share price encountered some volatility and closed at the lower circuit on day one.

With a clear strategic direction, healthy financial growth, and an attractive product portfolio, Medistep Healthcare stands poised to build on its early momentum.

The company’s prudent capital deployment and expanding manufacturing capabilities should enable it to meet growing demand and strengthen its competitive edge.

Investors and market watchers will be keenly observing Medistep Healthcare’s performance in the coming quarters, making it a stock to watch within the SME space of the Indian stock market.